Mike Hernandez

6PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 26, 2024
The Effects of Metformin on Cisplatin-Induced Ototoxicity in Diabetic Patients.

Marc-Elie Nader, Jonathan Choi, Mike Hernandez

|Oct 08, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).

Xiuning Le, Jyoti D Patel, Elaine Shum

|Jun 01, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.

Anne E O'Shea, Guy T Clifton, Na Qiao

|Oct 13, 2022
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.

Parijatham S Thomas, Anisha B Patel, J Jack Lee

|Jul 21, 2021
Temporal Bone Osteoradionecrosis: An 18-year, Single-Institution Experience.

Benjamin D Lovin, Mike Hernandez, Hunter Elms

Pageof 1

Frequent Collaborators

2 joint publications

Brandy M Heckman-Stoddard

2 joint publications

Jonathan S Choi

2 joint publications

Powel H Brown

2 joint publications

Eileen Dimond